| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/22/1996 | WO1996005221A1 Calcitonin receptor |
| 02/22/1996 | WO1996005217A1 Pharmaceutical compositions containing estra-1,3,5(10)-triene derivatives |
| 02/22/1996 | WO1996005216A1 Estra-1,3,5(10)-triene derivatives, methods of preparing such compounds and pharmaceutical compositions containing them |
| 02/22/1996 | WO1996005211A1 Ganglioside gm3 analog having sialic acid residue fluorinated at the 9-position and intermediate therefor |
| 02/22/1996 | WO1996005209A2 Sialic acid/fucose based medicaments |
| 02/22/1996 | WO1996005203A1 Spiro-substituted azacyclic derivatives and their use as therapeutic agents |
| 02/22/1996 | WO1996005200A1 TETRAHYDROPYRIDINYLMETHYL DERIVATIVES OF PYRROLO[2,3-b]PYRIDINE |
| 02/22/1996 | WO1996005196A1 Distamycin a analogues as antitumour or antiviral agents |
| 02/22/1996 | WO1996005195A1 Novel n-substituted naphthofused lactams |
| 02/22/1996 | WO1996005194A1 Cyclic benzazepine urea derivatives with aggregation-inhibiting effect |
| 02/22/1996 | WO1996005193A1 (azetidin-1-ylalkyl)lactams as tachykinin antagonists |
| 02/22/1996 | WO1996005191A1 Natriuretic cyclic compounds |
| 02/22/1996 | WO1996005190A1 3-benzoyl benzofuran derivatives as thyroid hormone antagonists |
| 02/22/1996 | WO1996005188A1 Hypolipidemic 1,4-benzothiazepine-1,1-dioxides |
| 02/22/1996 | WO1996005187A1 (4-(3-aminomethylphenyl)thiazol-2-yl)-guanidines as h2-receptor antagonists |
| 02/22/1996 | WO1996005185A1 Novel alkylamino derivatives as sigma 2 selective ligands |
| 02/22/1996 | WO1996005181A1 Morpholine derivatives and their use as therapeutic agents |
| 02/22/1996 | WO1996005177A1 Novel pyrimidine derivatives and processes for the preparation thereof |
| 02/22/1996 | WO1996005175A1 Synthetic excitatory amino acids |
| 02/22/1996 | WO1996005169A1 N,n-disubstituted amic acid derivative |
| 02/22/1996 | WO1996005165A1 Retinoic acid x-receptor ligands |
| 02/22/1996 | WO1996005164A1 Anti-inflammatory preparation |
| 02/22/1996 | WO1996005160A1 Oxidized carotenoids, retinoids and related conjugated polyenes, and derived fractions and compounds useful as cell-differentiation inducers, cytostatic agents, and anti-tumor agents |
| 02/22/1996 | WO1996004987A1 Self-emulsifying and/or emollient agents |
| 02/22/1996 | WO1996004943A1 Biologically compatible hydrogel |
| 02/22/1996 | WO1996004934A1 Retroviral vectors produced by producer cell lines resistant to lysis by human serum |
| 02/22/1996 | WO1996004932A1 Novel vaccine adjuvant and vaccine |
| 02/22/1996 | WO1996004928A1 Calcitonin gene related peptide receptor |
| 02/22/1996 | WO1996004924A1 Improved antiinfective polyoxypropylene/polyoxyethylene copolymers and methods of use |
| 02/22/1996 | WO1996004923A1 Methods for treating sepsis or inflammatory diseases with oxypurine nucleosides |
| 02/22/1996 | WO1996004921A1 TNFα-SECRETION INHIBITOR CONTAINING SYRINGIN OR ITS AGLYCONE |
| 02/22/1996 | WO1996004917A1 Remedy for myotonic dystrophy |
| 02/22/1996 | WO1996004916A1 Methods and compositions useful in prophylaxis and therapy of endotoxin related conditions |
| 02/22/1996 | WO1996004915A1 Methods for treating and/or preventing alzheimer's disease using phenothiazines and/or thioxanthenes |
| 02/22/1996 | WO1996004914A1 Triazine derivative and medicine |
| 02/22/1996 | WO1996004913A1 Hiv protease inhibitor combination |
| 02/22/1996 | WO1996004912A1 Use of ketoconazole and related substances in medicaments for treatment of type ii diabetes |
| 02/22/1996 | WO1996004911A1 Method of preventing and treating ophthalmic inflammation and/or wound |
| 02/22/1996 | WO1996004910A1 Treatment of opiate withdrawal syndrome |
| 02/22/1996 | WO1996004909A1 Use of quinone and hydroquinone derivatives for the teatment of cachexia |
| 02/22/1996 | WO1996004908A1 Pharmaceutical formulation containing amoxycillin and potassium clavulanate |
| 02/22/1996 | WO1996004907A1 Pharmaceutical formulation |
| 02/22/1996 | WO1996004906A1 Compounds for the treatment of restenosis |
| 02/22/1996 | WO1996004905A1 Phenoxyphenylacetic acid derivatives |
| 02/22/1996 | WO1996004904A1 Pharmaceutically stable oxaliplatinum preparation |
| 02/22/1996 | WO1996004903A1 Vascular smooth muscle cell migration inhibitor |
| 02/22/1996 | WO1996004902A1 Composition of external preparation |
| 02/22/1996 | WO1996004901A1 Composition and method for treating anxiety |
| 02/22/1996 | WO1996004900A1 Composition and method for protection against drug dependency |
| 02/22/1996 | WO1996004898A1 A method of treatment for malaria |
| 02/22/1996 | WO1996004897A1 Use of selegilin in the treatment of epilectic conditions |
| 02/22/1996 | WO1996004895A1 Anthracyclinone derivatives and their use in amyloidosis |
| 02/22/1996 | WO1996004894A1 Anti-acne cosmetic compositions |
| 02/22/1996 | WO1996004892A1 Novel cimetidine-containing compositions and combinations derived therefrom |
| 02/22/1996 | WO1996004891A1 Formulation and use of carotenoids in treatment of cancer |
| 02/22/1996 | WO1996004890A1 Vesicle formulation |
| 02/22/1996 | WO1996004889A1 Process for preparing beclomethasone dipropionate freon® clathrate |
| 02/22/1996 | WO1996004888A1 Oral compositions of h2-antagonists |
| 02/22/1996 | WO1996004886A2 Gelling compositions comprising optically enriched gellants |
| 02/22/1996 | WO1996004882A1 Denture adhesive |
| 02/22/1996 | WO1996004789A1 A method of selectively destroying neoplastic cells |
| 02/22/1996 | WO1996004788A1 Antisense and triplex therapeutic agents and methods |
| 02/22/1996 | WO1996004787A1 Combined virustatic antimediator (covam) treatment of common colds |
| 02/22/1996 | WO1996001110A3 Anti-hiv triple combination |
| 02/22/1996 | WO1996000068A3 Combination therapy for hiv infection |
| 02/22/1996 | DE4430593A1 Liposomal verkapseltes Taxol, seine Herstellung und seine Verwendung Liposomally encapsulated Taxol, its preparation and its use |
| 02/22/1996 | DE4429667A1 Estradiol-TTS mit wasserbindenden Zusätzen Estradiol-TTS with water-binding additives |
| 02/22/1996 | DE4429664A1 Estradiol-TTS mit wasserbindenden Zusätzen Estradiol-TTS with water-binding additives |
| 02/22/1996 | DE4429663A1 Transdermal therapeutic system for hydrolysable medicaments |
| 02/22/1996 | DE4429079A1 Cyclische Harnstoffderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung Cyclic urea derivatives, medicaments containing these compounds and processes for their preparation |
| 02/22/1996 | DE4428986A1 New alprazolam formulation with improved release kinetics |
| 02/22/1996 | DE4418691A1 3'-(4'-) nicht-radioaktiv markierte Nukleoside und Nukleotide mit Aminocarbonsäure-, Peptid- oder Carbonsäure-Spacer 3 '- (4') non-radioactively labeled nucleosides and nucleotides with aminocarboxylic acid, peptide or carboxylic acid-spacer |
| 02/22/1996 | CA2197789A1 Cyclic urea derivatives, pharmaceutical compositions comprising these compounds and processes for their preparation |
| 02/22/1996 | CA2197336A1 Sialic acid/fucose based medicaments |
| 02/22/1996 | CA2197205A1 Methods for treating sepsis or inflammatory diseases with oxypurine nucleosides |
| 02/22/1996 | CA2197195A1 Current-to-pressure transducer with selectable, adjustable input filter |
| 02/22/1996 | CA2197185A1 3-benzoyl benzofuran derivatives as thyroid hormone antagonists |
| 02/22/1996 | CA2197172A1 Novel alkylamino derivatives as sigma 2 selective ligands |
| 02/22/1996 | CA2197123A1 Method of preventing and treating ophthalmic inflammation and/or wound |
| 02/22/1996 | CA2197117A1 Antisense and triplex therapeutic agents and methods |
| 02/22/1996 | CA2197099A1 Hypolipidemic 1,4-benzothiazepine-1,1-dioxides |
| 02/22/1996 | CA2197091A1 Triazine derivative and medicine |
| 02/22/1996 | CA2196982A1 Anti-acne cosmetic compositions |
| 02/22/1996 | CA2196877A1 Novel n-substituted naphthofused lactams |
| 02/22/1996 | CA2196756A1 Enhanced activation of natural killer cells using an nk cell activator and a hydrogen peroxide scavenger or inhibitor |
| 02/22/1996 | CA2196694A1 Estra-1,3,5(10)-triene derivatives, process of preparing such compounds and pharmaceutical compositions containing them |
| 02/22/1996 | CA2196678A1 Pharmaceutical preparations containing estra-1,3,5(10)-triene derivatives |
| 02/22/1996 | CA2196529A1 Methods for treating and/or preventing alzheimer's disease using phenothiazines and/or thioxanthenes |
| 02/22/1996 | CA2196426A1 Use of quinone and hydroquinone derivatives for the teatment of cachexia |
| 02/22/1996 | CA2196422A1 Anti-inflammatory preparation |
| 02/22/1996 | CA2196208A1 Retroviral vectors produced by producer cell lines resistant to lysis by human serum |
| 02/22/1996 | CA2196203A1 Combined virustatic antimediator (covam) treatment of common colds |
| 02/22/1996 | CA2196171A1 Process for preparing beclomethasone dipropionate freon? clathrate |
| 02/22/1996 | CA2195972A1 Morpholine derivatives and their use as therapeutic agents |
| 02/22/1996 | CA2195782A1 Composition and method for treating anxiety |
| 02/22/1996 | CA2195779A1 Composition and method for protection against drug dependency |
| 02/22/1996 | CA2195758A1 Phenoxyphenylacetic acid derivatives |
| 02/22/1996 | CA2195757A1 Spiro-substituted azacyclic derivatives and their use as therapeutic agents |
| 02/22/1996 | CA2174232A1 Gene therapy for restenosis using an adenoviral vector |
| 02/22/1996 | CA2173623A1 Anthracyclinone derivatives and their use in amyloidosis |